About Harmony test

The Harmony prenatal test is backed by Roche
The Harmony prenatal test is backed by Roche.
  • Ariosa Diagnostics, Inc., the creator of the Harmony test, started offering the test in 2012
  • Ariosa Diagnostics joined Roche, a healthcare partner with a clinical mindset, in 2014
  • The Harmony prenatal test is a Roche offering. It is backed by 120+ years of Roche dedication and service
  • The test is supported by Roche’s strong technical support and responsible marketing
Roche in numbers
  • A pioneer in healthcare for >120 years
  • The frontrunner in personalized healthcare
  • The global leader in cancer treatment for over 50 years
  • The leading provider of in vitro diagnostics
  • World’s number one biotech company with 17 biopharmaceuticals in the market
  • Over 90,000 people working in more than 100 countries
 
 
Roche in numbers
Because when it comes to your baby’s health, trust is everything!
Patents

Ariosa Diagnostics, Inc. is a leading molecular diagnostics company committed to innovating together to improve patient care.  Ariosa’s technology can be found in its tests and services and in the tests and services offered by its commercial partners.

This page is intended to serve as notice under 35 U.S.C. § 287(a).

Harmony Prenatal Test®:  U.S. Patent Nos. 8,756,020, 8,712,697, 8,700,338.  Additional patents may be pending in the U.S. and elsewhere.

Director™ Software:  U.S. Patent Nos. 8,756,020, 8,712,697, 8,700,338.  Additional patents may be pending in the U.S. and elsewhere.

Because when it comes to your baby’s health, trust is everything!
  • Available in more than 100 countries1
  • Used in more than 2 million pregnancies1
  • Proven by more clinical evidence than any other test in the market2
  • More accurate than traditional screening3
  • Lower false positive rates than traditional screening3

References:

  1. Data on file.
  2. Demonstrated by 72 peer-reviewed published studies using the Harmony prenatal test as of January 2021.
  3. Norton et al. New England J of Medicine. 2015; 372(17):1589-1597.